Clinical Trial Update: Prophylactic Use of Entecavir for Non-Hodgkin's Lymphoma Patients With Resolved Hepatitis B [Phase 4]

View source ↗

Summary

Phase 4 trial investigating prophylactic entecavir to prevent hepatitis B reactivation in Non-Hodgkin lymphoma patients with resolved hepatitis B.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B
• Non-hodgkin Lymphoma

Drugs mentioned

• Baraclude (entecavir)

Snippet

Sponsor: Taipei Veterans General Hospital, Taiwan | Conditions: Non Hodgkin's Lymphoma, Hepatitis B | Phase 4 | Status: COMPLETED